...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone


BREAKING: American Creek Announces Additional $1,000,000 Strategic Financing with Eric Sprott

  • Intends to expand the non-brokered private placement in order to include an additional $1,000,000 investment by Eric Sprott
  • Darren Blaney, President & CEO of American Creek stated: “We welcome Mr. Sprott’s further support and additional significant contribution. We greatly appreciate not only his endorsement but also his enthusiasm for the future potential of American Creek’s vision and projects.

Hub On AGORACOM / Read Release

Message: AGM 2018 - Masila Notes

"Apparently all patients interviewed want to stay on the treatment.  Some have been on close to 36 months.  That speaks volumes to me! '

You must admit, however, that the statement "That speaks volumes to me" may be misconstrued to mean that the patients interviewed were on the Apabetalone treatment when they wouldn't have known which treatment they were on. Perhaps this is what DND was getting at.

And what does all patients mean? How many were actually interviewed?


Just saying...Koo


New Message
Please login to post a reply